Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Tops Revenue Estimates

Lyra Therapeutics, Inc. (LYRA) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.34. This compares to loss of $0.33 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 14.71%. A quarter ago, it was expected that this company would post a loss of $0.26 per share when it actually produced a loss of $0.35, delivering a surprise of -34.62%. Over the last four quarters, the company h ...